pyridostigmine bromide has been researched along with vecuronium bromide in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carter, ML; Karalliedde, L | 1 |
| Conforti, M; Duncalf, D; Foldes, FF; Goldiner, PL; Nagashima, H; Nguyen, HD | 1 |
| Albee, DT; Henry, JD; McAnallen, K; Yungbluth, J | 1 |
| Booij, LH; Crul, JF; Krieg, N; Mazur, L | 1 |
| Baraka, A; Rizkallah, P; Taha, S; Yazbeck, V | 1 |
| Mirakhur, RK | 1 |
| Antognini, JF; Fleming, NW; Macres, S; Vengco, J | 1 |
| Anderson, KA; Booij, LH; Hill, DR; Marshall, RJ; Muir, AW; Pow, E; Sleigh, T | 1 |
| Itoh, H; Nitta, S; Shibata, K | 1 |
| Cheong, MA; Cho, HY; Kim, KS; Lew, SH | 1 |
| Katz, RL; Lee, C | 1 |
2 review(s) available for pyridostigmine bromide and vecuronium bromide
| Article | Year |
|---|---|
Spontaneous recovery or evoked reversal of neuromuscular block.
Topics: Anesthesia Recovery Period; Atracurium; Cholinesterase Inhibitors; Edrophonium; Humans; Isoquinolines; Mivacurium; Neostigmine; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pyridostigmine Bromide; Time Factors; Vecuronium Bromide | 1995 |
Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
Topics: Androstanols; Anesthesia Recovery Period; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Drug Monitoring; Drug Utilization; Edrophonium; Forecasting; gamma-Cyclodextrins; Humans; Monitoring, Intraoperative; Neostigmine; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Patient Selection; Pyridostigmine Bromide; Rocuronium; Safety; Succinylcholine; Sugammadex; Vecuronium Bromide | 2009 |
3 trial(s) available for pyridostigmine bromide and vecuronium bromide
| Article | Year |
|---|---|
Recovery characteristics following antagonism of vecuronium with edrophonium, neostigmine or pyridostigmine.
Topics: Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Cholinesterase Inhibitors; Clinical Trials as Topic; Edrophonium; Female; Humans; Middle Aged; Neostigmine; Neuromuscular Junction; Pyridostigmine Bromide; Random Allocation; Vecuronium Bromide | 1988 |
Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
Topics: Adult; Aged; Anesthesia, General; Cholinesterase Inhibitors; Cholinesterases; Drug Interactions; Edrophonium; Female; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Depolarizing Agents; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pyridostigmine Bromide; Succinylcholine; Vecuronium Bromide | 1996 |
Sensitivity to vecuronium in seropositive and seronegative patients with myasthenia gravis.
Topics: Adult; Aged; Anesthesia; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Neuromuscular Nondepolarizing Agents; Pyridostigmine Bromide; Synaptic Transmission; Thymoma; Vecuronium Bromide | 2002 |
6 other study(ies) available for pyridostigmine bromide and vecuronium bromide
| Article | Year |
|---|---|
Effect of pretreatment with oral pyridostigmine.
Topics: Drug Interactions; Humans; Military Personnel; Neuromuscular Junction; Pyridostigmine Bromide; Vecuronium Bromide | 1992 |
A simple method for monitoring muscular relaxation during continuous infusion of vecuronium.
Topics: Adult; Aged; Anesthesia; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Monitoring, Physiologic; Muscle Contraction; Muscle Relaxation; Pyridostigmine Bromide; Vecuronium Bromide | 1988 |
Intubation conditions and reversibility of a new non-depolarizing neuromuscular blocking agent, Org-NC45.
Topics: Adult; Anesthesia; Blood Pressure; Heart Rate; Humans; Intubation, Intratracheal; Neostigmine; Neuromuscular Nondepolarizing Agents; Pancuronium; Pyridostigmine Bromide; Time Factors; Vecuronium Bromide | 1980 |
Vecuronium block in the myasthenic patient. Influence of anticholinesterase therapy.
Topics: Adolescent; Adult; Anesthesia, General; Cholinesterase Inhibitors; Drug Interactions; Female; Humans; Male; Muscle Contraction; Myasthenia Gravis; Nerve Block; Neuromuscular Junction; Pyridostigmine Bromide; Ulnar Nerve; Vecuronium Bromide | 1993 |
Neuromuscular blocking and cardiovascular effects of Org 9487, a new short-acting aminosteroidal blocking agent, in anaesthetized animals and in isolated muscle preparations.
Topics: Adrenergic alpha-Agonists; Animals; Cats; Chickens; Cholinesterase Inhibitors; Dogs; Dose-Response Relationship, Drug; Ganglionic Blockers; Guinea Pigs; Heart; Hemodynamics; Macaca mulatta; Male; Muscle, Skeletal; Neostigmine; Neuromuscular Blockade; Neuromuscular Depolarizing Agents; Neuromuscular Nondepolarizing Agents; Norepinephrine; Pyridostigmine Bromide; Rats; Rats, Wistar; Succinylcholine; Time Factors; Vagus Nerve; Vecuronium Bromide | 1998 |
Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine.
Topics: Adult; Androstanols; Female; Humans; Male; Middle Aged; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pyridostigmine Bromide; Rocuronium; Vecuronium Bromide | 2002 |